Skiba J, Kołtuniewicz R, Sukiennik-Kujawa M. Biocomplex Mitrofix as a new alternative to reconstructive surgery
of mitral valve – preliminary observations and results. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery. 2012;9(1):11-15.
APA
Skiba, J., Kołtuniewicz, R., & Sukiennik-Kujawa, M. (2012). Biocomplex Mitrofix as a new alternative to reconstructive surgery
of mitral valve – preliminary observations and results. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, 9(1), 11-15.
Chicago
Skiba, Jacek, Rafał Kołtuniewicz, and Małgorzata Sukiennik-Kujawa. 2012. "Biocomplex Mitrofix as a new alternative to reconstructive surgery
of mitral valve – preliminary observations and results". Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery 9 (1): 11-15.
Harvard
Skiba, J., Kołtuniewicz, R., and Sukiennik-Kujawa, M. (2012). Biocomplex Mitrofix as a new alternative to reconstructive surgery
of mitral valve – preliminary observations and results. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, 9(1), pp.11-15.
MLA
Skiba, Jacek et al. "Biocomplex Mitrofix as a new alternative to reconstructive surgery
of mitral valve – preliminary observations and results." Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, vol. 9, no. 1, 2012, pp. 11-15.
Vancouver
Skiba J, Kołtuniewicz R, Sukiennik-Kujawa M. Biocomplex Mitrofix as a new alternative to reconstructive surgery
of mitral valve – preliminary observations and results. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery. 2012;9(1):11-15.
Mitral valve repair procedures are preferable methods of treatment for patients with mitral valve dysfunction in modern cardiothoracic surgery. It is nowadays an alternative to mitral valve replacement. Between 23.05.11 and 13.10.11 we performed 8 Mitrofix device implantations. We report our preliminary results of the first 4 cases with full 3-month follow-up.